Your browser doesn't support javascript.
loading
Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT6 antagonists.
Hu, Shuanghua; Huang, Yazhong; Wu, Yong-Jin; He, Huan; Grant-Young, Katherine A; Bertekap, Robert L; Whiterock, Valerie; Brassil, Patrick; Lentz, Kimberley; Sivaprakasam, Prasanna; Langley, David R; Westphal, Ryan S; Scola, Paul M.
Afiliação
  • Hu S; Bristol-Myers Squibb Research and Development, Discovery Chemistry, 5 Research Parkway, Wallingford, CT 06492, USA. Electronic address: shuanghua.hu@bms.com.
  • Huang Y; Bristol-Myers Squibb Research and Development, Discovery Chemistry, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Wu YJ; Bristol-Myers Squibb Research and Development, Discovery Chemistry, 5 Research Parkway, Wallingford, CT 06492, USA.
  • He H; Bristol-Myers Squibb Research and Development, Discovery Chemistry, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Grant-Young KA; Bristol-Myers Squibb Research and Development, Discovery Chemistry, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Bertekap RL; Bristol-Myers Squibb Research and Development, Biology Neuroscience, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Whiterock V; Bristol-Myers Squibb Research and Development, Pharmaceutical Candidate Optimization, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Brassil P; Bristol-Myers Squibb Research and Development, Pharmaceutical Candidate Optimization, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Lentz K; Bristol-Myers Squibb Research and Development, Pharmaceutical Candidate Optimization, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Sivaprakasam P; Bristol-Myers Squibb Research and Development, Computer Assisted Drug Design, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Langley DR; Bristol-Myers Squibb Research and Development, Computer Assisted Drug Design, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Westphal RS; Bristol-Myers Squibb Research and Development, Biology Neuroscience, 5 Research Parkway, Wallingford, CT 06492, USA.
  • Scola PM; Bristol-Myers Squibb Research and Development, Discovery Chemistry, 5 Research Parkway, Wallingford, CT 06492, USA.
Bioorg Med Chem ; 22(5): 1782-90, 2014 Mar 01.
Article em En | MEDLINE | ID: mdl-24495863
ABSTRACT
Comprehensive structure activity relationship (SAR) studies were conducted on a focused screening hit, 2-(methylthio)-3-(phenylsulfonyl)-4H-pyrido[1,2-a]pyrimidin-4-imine (1, IC50 4.0 nM), as 5-HT6 selective antagonists. Activity was improved some 2-4 fold when small, electron-donating groups were added to the central core as observed in 19, 20 and 26. Molecular docking of key compounds in a homology model of the human 5-HT6 receptor was used to rationalize our structure-activity relationship (SAR) findings. In pharmacokinetic experiments, compound 1 displayed good brain uptake in rats following intra-peritoneal administration, but limited oral bioavailability.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Serotonina / Doença de Alzheimer / Iminas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Serotonina / Doença de Alzheimer / Iminas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2014 Tipo de documento: Article